A new bioinformatics company, Nostrum BioDiscovery, a spin-out created through the combined efforts of The Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) – has been created to accelerate drug discovery through the application of high-performance computing.
Continue reading here.